Pre-market Movers: BKKT, HI, NE, SA, HLX…

us pre market 053119 27sep22 lt

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 06.40 A.M. ET).

In the Green

Bakkt Holdings, Inc. (BKKT) is up over 12% at $2.46
Noble Corporation (NE) is up over 10% at $29.82
Seabridge Gold Inc. (SA) is up over 10% at $11.55
Helix Energy Solutions Group, Inc. (HLX) is up over 9% at $4.08
Genius Group Limited (GNS) is up over 8% at $2.39
AMC Entertainment Holdings, Inc. (APE) is up over 7% at $3.62
MicroStrategy Incorporated (MSTR) is up over 6% at $212.75
Blue Apron Holdings, Inc. (APRN) is up over 6% at $4.78
BeiGene, Ltd. (BGNE) is up over 5% at $139.06
Studio City International Holdings Limited (MSC) is up over 5% at $2.59
Gold Royalty Corp. (GROY) is up over 5% at $2.34

In the Red

Hillenbrand, Inc. (HI) is down over 10% at $32.99
HeartBeam, Inc. (BEAT) is down over 8% at $2.28
Hempacco Co., Inc. (HPCO) is down over 6% at $2.13
Loop Media, Inc. (LPTV) is down over 5% at $4.43

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. plans to start using American-made processors from the new advanced chip factory in Phoenix, Arizona operated by chip giant Taiwan Semiconductor Manufacturing Co., according to its Chief Executive Officer Tim Cook. At an event in the factory in Arizona, which was attended by U.S. President Joe Biden, it was also announced that TSMC will invest $40 billion in the new factory. Lidl US has recalled its 8.4 oz Favorina branded Advent Calendar, i.e., Premium Chocolate with a Creamy Filling, citing potential Salmonella contamination, the U.S. Food and Drug Administration said. The products were available for sale at Lidl stores between October 12, 2022 and December 5, 2022. They will have a BEST IF USED BY year of 2023, and barcode number of 4056489516965. Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary series for children in this age group.
Follow RTT